The Rosiglitazone reference article from the English Wikipedia on 24-Apr-2004 (provided by Fixed Reference: snapshots of Wikipedia from wikipedia.org)

Rosiglitazone

In medicine and pharmacology, rosiglitazone is a member of the drug class of the thiazolidinediones.

It is being marketed as Avandia® by the pharmaceutical company GlaxoSmithKline, both as a standalone preparation and in combination with metformin (Avandamet®).

Like other thiazolidinediones, its mechanism of action is by activation the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.

Table of contents

1 Side-effects and contraindications 2 See also 3 External links

Side-effects and contraindications

See main article: thiazolidinedione

See also

• Anti-diabetic drugs
• Peroxisome proliferator-activated receptor

External links

• Diabetes monitor article
• MedlinePlus article

This is the "Rosiglitazone" reference article from the English Wikipedia. All text is available under the terms of the GNU Free Documentation License. See also our Disclaimer.